NOVARTIS GRIMSBY LIMITED

• ⚠

  Material uncertainty over going concern

  Novartis Grimsby Limited has ceased operation during the previous year and management have plans to liquidate this entity. The company now does not have relationships with employees, suppliers and customers. The Directors consider they have complied with all the requirements of S172(1).

1. NOVARTIS GRIMSBY LIMITED 1998-12-23 → present
2. CIBA-GEIGY LIMITED 1982-06-28 → 1998-12-23
3. CIBA-GEIGY (UK) PLC 1920-09-11 → 1982-06-28

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“Novartis Grimsby Limited has ceased operation during the previous year and management have plans to liquidate this entity. The company now does not have relationships with employees, suppliers and customers. The Directors consider they have complied with all the requirements of S172(1).”

Significant events

• “The principal activity of the Company was to perform the tasks of a toll manufacturing within the Novartis Group. Specifically during 2023 the Company prepared and cleaned the manufacturing facilities for sale to third party. The site was sold to the third party in December 2023.”
• “In June 2021 (an extension from the original announcement in September 2018), Novartis AG confirmed that manufacturing at the Grimsby site would cease in December 2022, in alignment with the wider Novartis business strategy. In April 2022, an agreement was made to sell the remaining Plant, Building and Land assets to a third party in December 2023, following the finalisation of cleaning activities. In December 2023 the site was sold to a third party.”
• “Due to the wind down of activities, all employees left Novartis Grimsby by end of 2023.”
• “The company had leases during part of the year in FY23 and were transferred /terminated during FY23”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

9

last 12 months

Capital events

2

last 24 months

Officers appointed

2

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -100%

  £3,249,000 → £0

• Cash

  —

  Not reported

• Net assets

  +1.7%

  £262,696,000 → £267,176,000

• Employees

  -100%

  71 → 0

• Operating profit

  +99.7%

  -£9,895,000 → -£33,000

• Profit before tax

  +302.1%

  -£5,688,000 → £11,497,000

• Wages

  -99%

  £865,000 → £9,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers